Almac launches mobile website in response to large mobile user base

July 2, 2012

Embedded mobile icon means website can be accessed on the move in just one click

Almac is pleased to announce the launch of a mobile optimized version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready site (designed to work with all mobile operating systems including Android and Apple) contains shortened summaries of all the sections of Almac’s full website broken-down into 6 tabs – ‘Services’, ‘News’, ‘Events’, ‘Locations’, ‘Contact Us’, and ‘Vacancies’.

The new website was created in response to client demands; due to an ever growing number of visitors accessing the main site via mobile devices. The mobile ready site enables users to store an Almac icon on their phone’s screen providing rapid access in just one click, enhanced resolution for all screens sizes, and a search facility enabling visitors to access any content from the full site.

“At Almac we are always looking to help clients with any requirements they have and by launching this new mobile website we are providing even greater accessibility for the significant number of people that view our services and locations through mobile devices.  We are one of the first CDMO companies to invest in online technologies to respond to this growing need, providing up to date information on our global portfolio helping to facilitate real time decision making wherever you are” said Philip Diamond, VP Corporate Market Development at Almac.

The new site can be visited on the following address:

Notes to Editors

About Almac:

The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.  The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.


Back to news